(Q47741135)

English

Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

1 reference

based on heuristic

inferred from title

fluticasone propionate

1 reference

based on heuristic

inferred from title

author name string

Nimmagadda SR

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Spahn JD

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Nelson HS

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Jenkins J

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Szefler SJ

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Leung DY

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

81

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

35-40

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Glucocorticoid therapy for asthma: clinical pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid-resistant asthma: evaluation and management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the relative systemic potency of inhaled fluticasone and budesonide.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963107-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)63107-9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9690571

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47741135&oldid=2169209019"